Explore RLT services
Our all-encompassing service aims to simplify the RLT journey and minimise time-to-treatment for your eligible patients.
This page is intended for UK healthcare professionals and other relevant decision makers only. If you are a member of the public, please click here.
This portal is funded and owned by Novartis Pharmaceuticals UK Ltd and includes content approved by Novartis.
Adverse events reporting information can be found in the footer of this page.
This link will take you to the electronic medicines compendium (emc) website, which is a non-Novartis website.
UK | October 2025 | FA-11470150
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report, or alternatively email [email protected] or call 01276 698370.